Navigation Links
Cost of prostate cancer care varies with initial treatment choice

A new analysis has found that short-term and long-term costs of prostate cancer care vary considerably based on which treatment strategy a man initially receives. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study finds that treatments that may be less expensive in the short-term may have higher long-term costs.

For men with early stage prostate cancer, various treatments are available, including surgery, radiation therapy, hormonal treatment, watchful waiting, or combinations of the above. A variety of factors determines which treatment is appropriate for a given man, and in some cases, a man may be able to choose among several options. Cost is one of many factors to consider when choosing among these options.

To determine how the initial treatment received by men with early stage prostate cancer affects costs of medical care both in the short-term (first year following diagnosis) and long-term (across five years of follow-up), Claire Snyder, PhD, of the Johns Hopkins School of Medicine and the Johns Hopkins Bloomberg School of Public Health in Baltimore led a team that reviewed early stage prostate-cancer cases from the Surveillance, Epidemiology and End Results (SEER)-Medicare database. (This database combines cancer incidence and survival data from US population-based cancer registries with Medicare administrative claims.) Patients included 13,769 men aged 66 years or older who were diagnosed in 2000 and were followed for 5 years. They were divided into groups based on the treatment they received during the first 9 months after diagnosis: watchful waiting, radiation, hormonal therapy, hormonal therapy plus radiation, and surgery (men in this latter group may have received hormones and/or radiation as well). Treatment costs were divided into initial (months -1 to 12), long-term (each 12 months thereafter), and total (months -1 to 60) costs. The incremental costs of care were calculated as the difference in medical costs for patients versus a group of similar men without cancer.

The investigators found that for most prostate cancer cases, costs were highest in the initial year and then dropped sharply and remained steady over the next several years; however, patterns of costs varied widely in the short-term and long-term based on initial treatment received. Watchful waiting had the lowest initial ($4270) and five-year total costs ($9130). Initial treatment costs were highest for patients who received hormonal therapy plus radiation ($17,474), followed by those undergoing surgery ($15,197). Hormonal therapy had the second lowest initial costs but the highest five-year total costs ($26,896). "This demonstrates that treatments that may be less expensive in the short-term may have higher long-term costs," said Dr. Snyder. Hormonal therapy plus radiation ($25,097) and surgery ($19,214) had the second and third highest five-year total costs. After excluding the last 12 months of life (because patterns of costs are quite different in the period prior to death), total costs were highest for hormonal therapy plus radiation ($23,488) and hormonal therapy only ($23,199).

These findings provide new information for patients, providers, and payers involved in prostate cancer care. Despite the high prevalence of early stage prostate cancer and the controversies associated with determining initial treatment, few other studies have examined both the short-term and long-term costs of available treatment options.


Contact: David Sampson
American Cancer Society

Related medicine news :

1. Advance Toward Test for Aggressive Prostate Cancer
2. DASH FOR DAD Race Series Coming to 11 Cities to Raise Prostate Cancer Awareness
3. Jim Huber to Serve as National Spokesman for Know Your Score: Fight Prostate Campaign at Myrtle Beach Golf Holiday in August
4. Few differences in outcomes between open and laparoscopic prostate surgery
5. Two Surgical Methods Equally Successful for Prostate Cancer
6. Genetic Mutation Linked to Prostate Cancer in Blacks
7. Statins May Benefit Prostate Cancer Patients
8. Demand For Mobile Prostate Cancer Brachytherapy Vendor Programs Continues Into 2010
9. Be a Star Athlete in the Fight Against Prostate Cancer
10. Do men with early prostate cancer commit suicide more frequently?
11. Effective prostate cancer treatment discovery
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... ... states in the U.S. require dental technicians to be certified or obtain continuing ... NADL created the “What’s In Your Mouth?” campaign to inform dentists that the ...
(Date:11/30/2015)... Los Angeles, CA (PRWEB) , ... November 30, 2015 , ... ... such as grafts, strip harvesting and follicular unit extraction. These techniques and procedures have ... of helping patients suffering from hair loss. While Dr. Parsa Mohebi, M.D. has utilized ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... its annual fundraising campaign to raise funds for its research, education, support, and ... of the organization’s annual funding. , The Mesothelioma Applied Research Foundation, which also ...
(Date:11/30/2015)... ... , ... Cycling, running, and walking are regular Sunday activities for many South ... 28, 2016. , That’s when the 7th annual ANF Group Tour de Broward ... and families at Joe DiMaggio Children’s Hospital. , The community fundraiser, sponsored ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... athletic teams looking to maximize recovery through quality sleep. Tim DiFrancesco, training coach ... get a better night’s sleep. ChiliPad precisely regulates the surface temperature of each ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Nov. 30, 2015 Baxalta Incorporated ... leader dedicated to delivering transformative therapies to ... conditions, today announced the launch and first ... an extended circulating half-life recombinant factor VIII ... full-length ADVATE [Antihemophilic Factor (Recombinant)]. The treatment ...
(Date:11/30/2015)... 2015 (HK$,000)For the Six Months Ended 30 September 2015 2014RestatedChange%Turnover 545,575 ... 421,979 , 384,242 , 9.8 ... 34,719 , (18.3) Medical Insurance Administration Service Income ... 16.1 Medical Devices and Accessories Sales , 89,645 ... Medicines Sales , 2,822 , 2,917 ...
(Date:11/30/2015)... , November 30, 2015 --> ... report "Dental Lasers Market by Product (Soft Tissue, All Tissue, ... User (Hospitals, Clinics), and Geography - Global Forecast to 2020", ... by 2020, at a CAGR of 5.2% during the forecast ... market data Tables and 62 Figures spread through 167 P ...
Breaking Medicine Technology: